MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/jcla.70059

Медицинская библиотека · Journal of clinical laboratory analysis · 2025

Significance of Inflammation Markers to Predict Curative Treatment for Prostate Cancer Patients on Active Surveillance.

Serkan Yenigürbüz, Caner Ediz, Serkan Akan, Bulent Kati, Yasin Vural, Adem Alcin, Omer Yilmaz

СтатьяПеревод в очереди

Аннотация

PURPOSE: Active surveillance (AS) strategy aims to avoid unnecessary or excessive early treatment in patients at a low risk for prostate cancer (PCa). However, a biomarker that can predict the need for early curative treatment in patients under AS has not been identified to date. In this study, we aimed to investigate the potential of inflammatory biomarkers in predicting the requirement of curative treatment in the early period in patients under AS.

MATERIALS AND

METHODS

This study included a total of 83 patients with the diagnosis of PCa and under AS. Patient age, prostate-specific antigen (PSA) level, prostate volume (PV), PSA density (PSAD), neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), systemic immune-inflammation index (SII) and follow-up period were compared between the groups.

RESULTS

There was a significant difference between the two groups in terms of PSAD, NLR, PLR and SII (p = 0.037, p = 0.046, p = 0.008, p = 0.004 and p = 0.005, respectively). The cut-off value determined by performing ROC analysis to evaluate the levels that predict the need for curative treatment before AS was 0.125 for PSAD (sensitivity: 61.8%, specificity: 61.2%), 2.01 for NLR (sensitivity: 67.6%, specificity: 55.1%), 115.49 for PLR (sensitivity: 73.5%, specificity: 59.2%) and 465.40 for SII (sensitivity: 70.6%, specificity: 59.2%).

CONCLUSIONS

The analysis of PSAD, NLR, PLR and SII before making the decision to conduct AS can guide clinicians regarding curative treatment in the early period.

Для цитирования: Serkan Yenigürbüz, Caner Ediz, Serkan Akan, Bulent Kati, Yasin Vural, Adem Alcin, Omer Yilmaz. Significance of Inflammation Markers to Predict Curative Treatment for Prostate Cancer Patients on Active Surveillance.. Journal of clinical laboratory analysis. 2025. DOI: 10.1002/jcla.70059.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.